Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongling Zou

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|April 11, 2026
Unbiased profiling of translational landscape reveals TNFR2 as a translation-dependent vulnerability in colorectal cancerYiying Chen, Yufeng Gao, Haixia Wang, et al.
Annals of Translational Medicine|January 20, 2023
HPV and radiosensitivity of cervical cancer: a narrative reviewYue Huang, Dongling Zou, Mingfang Guo, et al.
Journal of Ovarian Research|July 1, 2026
An organoid-guided platform for ovarian cancer: enabling prediction of patients' chemotherapy responseLing Wang, Misi He, Xueping Zhu, et al.
Chinese Medical Journal|July 25, 2025
Development and validation of deep learning for predicting the growth of ovarian cancer organoidsHongji Wu, Lifang Ma, Ling Wang, et al.
Oncotarget|November 19, 2016
Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroidsMisi He, Dong Wang, Dongling Zou, et al.
BMC Cancer|October 2, 2025
Prognostic factors of locally advanced cervical cancer after concurrent chemoradiotherapy: a retrospective studyXiuying Li, Zejia Mao, Qiaoling Li, et al.
Cell & Bioscience|January 23, 2021
SOX4 maintains the stemness of cancer cells via transcriptionally enhancing HDAC1 revealed by comparative proteomics studyJingshu Liu, Jiangfeng Qiu, Zhiqi Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 21, 2023
Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA/YAP axisYunzhe Li, Yunran Hu, Lingling Yang, et al.
Journal of Translational Medicine|January 6, 2026
Patient-derived organoids predict responses to chemotherapy and PARP inhibitors in advanced ovarian cancerHaixia Wang, Ling Wang, Xueping Zhu, et al.
British Journal of Cancer|January 22, 2024
Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancersYi Wang, Misi He, Tiancong He, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Journal of Experimental & Clinical Cancer Research : CR|April 11, 2026
Unbiased profiling of translational landscape reveals TNFR2 as a translation-dependent vulnerability in colorectal cancerYiying Chen, Yufeng Gao, Haixia Wang, et al.
Annals of Translational Medicine|January 20, 2023
HPV and radiosensitivity of cervical cancer: a narrative reviewYue Huang, Dongling Zou, Mingfang Guo, et al.
Journal of Ovarian Research|July 1, 2026
An organoid-guided platform for ovarian cancer: enabling prediction of patients' chemotherapy responseLing Wang, Misi He, Xueping Zhu, et al.
Chinese Medical Journal|July 25, 2025
Development and validation of deep learning for predicting the growth of ovarian cancer organoidsHongji Wu, Lifang Ma, Ling Wang, et al.
Oncotarget|November 19, 2016
Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroidsMisi He, Dong Wang, Dongling Zou, et al.
BMC Cancer|October 2, 2025
Prognostic factors of locally advanced cervical cancer after concurrent chemoradiotherapy: a retrospective studyXiuying Li, Zejia Mao, Qiaoling Li, et al.
Cell & Bioscience|January 23, 2021
SOX4 maintains the stemness of cancer cells via transcriptionally enhancing HDAC1 revealed by comparative proteomics studyJingshu Liu, Jiangfeng Qiu, Zhiqi Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 21, 2023
Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA/YAP axisYunzhe Li, Yunran Hu, Lingling Yang, et al.
Journal of Translational Medicine|January 6, 2026
Patient-derived organoids predict responses to chemotherapy and PARP inhibitors in advanced ovarian cancerHaixia Wang, Ling Wang, Xueping Zhu, et al.
British Journal of Cancer|January 22, 2024
Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancersYi Wang, Misi He, Tiancong He, et al.
Pageof 7